SCHEMBL21639611

SCHEMBL21639611

CC(C)(C)OC(=O)c1ccc(NC(=O)CC(=O)O)cc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.58
▸ MEN1 O00255 2/20 0.58
▸ TMPRSS6 Q8IU80 2/20 0.50
▸ F2 P00734 2/20 0.50
▸ TSHR P16473 1/20 0.50
▸ RAB9A P51151 6/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ STAT3 P40763 2/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ MAPT P10636 2/20 0.48
▸ LMNA P02545 1/20 0.48
▸ HTR1A P08908 1/20 0.46
▸ HTR7 P34969 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ ABCG2 Q9UNQ0 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17368421 0.86 RAB9A (0.57) KMT2AMEN1TMPRSS6F2TSHR
SCHEMBL11913978 0.85 ALDH1A1 (0.56) KMT2AMEN1TMPRSS6F2ALDH1A1
SCHEMBL14116517 0.84 MEN1 (0.54) KMT2AMEN1TMPRSS6F2TSHR
SCHEMBL7925092 0.84 MEN1 (0.54) KMT2AMEN1TMPRSS6F2TSHR
SCHEMBL14861108 0.84 CYP17A1 (0.52) KMT2AMEN1RAB9AMAPTGAA
SCHEMBL17368420 0.83 TP53 (0.58) KMT2AMEN1TSHRRAB9ANPC1
SCHEMBL21639456 0.82 TSHR (0.76) KMT2AMEN1TSHRRAB9ANPC1
SCHEMBL25733667 0.81 MEN1 (0.54) KMT2AMEN1TMPRSS6F2RAB9A
SCHEMBL23176635 0.80 MAPT (0.61) KMT2AMEN1TSHRRAB9ANPC1
SCHEMBL16639670 0.80 KMT2A (0.54) KMT2AMEN1TSHRSTAT3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210070747-A1 2(1H)-QUINOLINONE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2021-03-11 — — US disclosed
US-20210070747-A1 2(1H)-QUINOLINONE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2021-03-11 — — US disclosed
EP-3604281-A1 2(1H)-QUINOLINONE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2020-02-05 — — EP disclosed
EP-3604281-A1 2(1H)-QUINOLINONE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2020-02-05 — — EP disclosed
CN-110446699-A 2(1H) -quinolinone derivatives TAISHO PHARMACEUTICAL CO LTD 2019-11-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070747-A1 2(1H)-QUINOLINONE DERIVATIVE TOP2A, TOP2B, TOP1 KMT2A 1731/4885MEN1 3375/4885TMPRSS6 1054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback